Old Mission Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Old Mission Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,875	Closed	-$1.47M	–	1070
2022 Q2	$1.47M	Sell	10,875 -18,420	-63%	-$2.54M	0.04%	426
2022 Q1	$4.37M	Buy	+29,295	New	+$4.33M	0.12%	140
2019 Q4	–	Sell	-2,893	Closed	-$358K	–	321
2019 Q3	$358K	Buy	+2,893	New	+$385K	0.04%	160

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Old Mission Capital's FBT Position: Q3 2022 in Review

Old Mission Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 10,875 shares — an estimated $1.47M sold.

Old Mission Capital first reported a position in FBT in Q3 2019 and held it in 3 quarters. The position peaked at $4.37M in Q1 2022. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

Old Mission Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
Old Mission Capital sold 10,875 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $1.47M.
Old Mission Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2019 and held it in 3 quarters.
Old Mission Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.37M in Q1 2022.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Old Mission Capital's 13F filing for Q3 2022, filed 14 Nov 2022.